Cubist Systematic Strategies’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.76M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $3.87M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $637K | Buy |
|
|||||
|
2023
Q4 | $581K | Sell |
|
|||||
|
2023
Q3 | $754K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.38M | Sell |
|
|||||
|
2022
Q4 | $5.97M | Buy |
|
|||||
|
2022
Q3 | $4.89M | Buy |
|
|||||
|
2022
Q2 | $4.51M | Buy |
|
|||||
|
2022
Q1 | $842K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.79M | Buy |
|
|||||
|
2021
Q2 | $3.09M | Buy |
|
|||||
|
2021
Q1 | $189K | Sell |
|
|||||
|
2020
Q4 | $2.46M | Sell |
|
|||||
|
2020
Q3 | $928K | Sell |
|
|||||
|
2020
Q2 | $1.26M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $171K | Sell |
|
|||||
|
2018
Q4 | $733K | Buy |
|
|||||
|
2018
Q3 | $157K | Sell |
|
|||||
|
2018
Q2 | $346K | Buy |
|
|||||
|
2018
Q1 | $252K | Buy |
|